Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers

被引:14
作者
Alizadeh, Anita [1 ]
Jebelli, Asiyeh [1 ]
Baradaran, Behzad [2 ]
Amini, Mohammad [2 ]
Oroojalian, Fatemeh [3 ]
Hashemzaei, Mahmoud [4 ]
Mokhtarzadeh, Ahad [2 ]
Hamblin, Michael R. [5 ,6 ]
机构
[1] Higher Educ Inst Rab Rashid, Fac Basic Sci, Dept Biol Sci, Tabriz, Iran
[2] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[3] North Khorasan Univ Med Sci, Dept Adv Sci & Technol, Bojnurd, Iran
[4] Zabol Univ Med Sci, Sch Pharm, Dept Pharmacodynam & Aptameol, Zabol, Iran
[5] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA
[6] Univ Johannesburg, Fac Hlth Sci, Laser Res Ctr, ZA-2028 Doornfontein, South Africa
关键词
LncRNA; DLX6-AS1; miRNA; Cancer; Therapeutic target; Diagnostic biomarker; EPITHELIAL-MESENCHYMAL TRANSITION; INHIBITS CELL-PROLIFERATION; COMPETING ENDOGENOUS RNA; LNCRNA DLX6-AS1; OVARIAN-CANCER; PROMOTES APOPTOSIS; INVASION; EPIDEMIOLOGY; MIGRATION; PROGRESSION;
D O I
10.1016/j.gene.2020.145224
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Long non-coding RNAs (lncRNAs) are a type of non-protein coding RNA, which have been found to play multiple roles in various molecular and cellular processes by epigenetic regulation of gene expression at post transcriptional levels. LncRNAs may act either as an oncogene or as a tumor suppressor gene in different cancers. Aberrant expression and dysregulation of lncRNAs has been correlated with cancer development and tumor growth via several different signaling pathways. Therefore, lncRNAs could serve as diagnostic biomarkers and as therapeutic targetes in many human cancers. Previous studies have reported that dysregulated expression of the lncRNA called DLX6-AS1 in various cancer types, such as lung, colorectal, bladder, ovarian, hepatocellular, pancreatic and gastric. DLX6-AS1 plays an important role in tumorigenesis by affecting cell proliferation, migration, invasion, EMT, and apoptosis. DLX6-AS1 exerts these regulatory effects by interfering with various microRNA axes and signaling pathways including, Wnt/beta catenin, Notch, P13/AKT/mTOR, and STAT3. This review focuses on the possible mechanisms by which DLX6-AS1 regulates tumor initiation and progression. Accordingly, DLX6-AS1 may act as a novel potential biomarker for cancer diagnosis or therapy in future.
引用
收藏
页数:12
相关论文
共 113 条
[1]   LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181 b in pancreatic cancer [J].
An, Yong ;
Chen, Xue-min ;
Yang, Yong ;
Mo, Feng ;
Jiang, Yong ;
Sun, Dong-lin ;
Cai, Hui-hua .
CANCER CELL INTERNATIONAL, 2018, 18
[2]  
[Anonymous], 2019, ONCOLOGY-BASEL
[3]   Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends [J].
Antoni, Sebastien ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Znaor, Ariana ;
Jemal, Ahmedin ;
Bray, Freddie .
EUROPEAN UROLOGY, 2017, 71 (01) :96-108
[4]   microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities [J].
Asadzadeh, Zahra ;
Mansoori, Behzad ;
Mohammadi, Ali ;
Aghajani, Marjan ;
Haji-Asgarzadeh, Khalil ;
Safarzadeh, Elham ;
Mokhtarzadeh, Ahad ;
Duijf, Pascal H. G. ;
Baradaran, Behzad .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (07) :10002-10017
[5]   Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes [J].
Asombang, Akwi W. ;
Chishinga, Nathaniel ;
Nkhoma, Alick ;
Chipaila, Jackson ;
Nsokolo, Bright ;
Manda-Mapalo, Martha ;
Montiero, Joao Filipe G. ;
Banda, Lewis ;
Dua, Kulwinder S. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (31) :4512-4533
[6]   ZOCB and ZOTR: Tweakable Blockcipher Modes for Authenticated Encryption with Full Absorption [J].
Bao, Zhenzhen ;
Guo, Jian ;
Iwata, Tetsu ;
Minematsu, Kazuhiko .
IACR TRANSACTIONS ON SYMMETRIC CRYPTOLOGY, 2019, 2019 (02) :1-54
[7]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[8]   Emerging roles of long non-coding RNA in cancer [J].
Calle, Anna Sanchez ;
Kawamura, Yumi ;
Yamamoto, Yusuke ;
Takeshita, Fumitaka ;
Ochiya, Takahiro .
CANCER SCIENCE, 2018, 109 (07) :2093-2100
[9]   The transcriptional landscape of the mammalian genome [J].
Carninci, P ;
Kasukawa, T ;
Katayama, S ;
Gough, J ;
Frith, MC ;
Maeda, N ;
Oyama, R ;
Ravasi, T ;
Lenhard, B ;
Wells, C ;
Kodzius, R ;
Shimokawa, K ;
Bajic, VB ;
Brenner, SE ;
Batalov, S ;
Forrest, ARR ;
Zavolan, M ;
Davis, MJ ;
Wilming, LG ;
Aidinis, V ;
Allen, JE ;
Ambesi-Impiombato, X ;
Apweiler, R ;
Aturaliya, RN ;
Bailey, TL ;
Bansal, M ;
Baxter, L ;
Beisel, KW ;
Bersano, T ;
Bono, H ;
Chalk, AM ;
Chiu, KP ;
Choudhary, V ;
Christoffels, A ;
Clutterbuck, DR ;
Crowe, ML ;
Dalla, E ;
Dalrymple, BP ;
de Bono, B ;
Della Gatta, G ;
di Bernardo, D ;
Down, T ;
Engstrom, P ;
Fagiolini, M ;
Faulkner, G ;
Fletcher, CF ;
Fukushima, T ;
Furuno, M ;
Futaki, S ;
Gariboldi, M .
SCIENCE, 2005, 309 (5740) :1559-1563
[10]   Gastric Cancer: Overview [J].
Correa, Pelayo .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2013, 42 (02) :211-+